UW Quitting Using Intensive Treatment Study (QUITS)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,251

Participants

Timeline

Start Date

November 11, 2017

Primary Completion Date

July 9, 2020

Study Completion Date

July 9, 2020

Conditions
Tobacco Dependence
Interventions
DRUG

Varenicline

0.5mg and 1.0 mg pills used. See arms for specific durations. (Active and placebo varenicline pills provided at no cost through an independent research agreement with Pfizer.)

DRUG

Nicotine patch

14 mg and 7 mg nicotine patches used. See arms for specific durations.

OTHER

Placebo Patch

Placebo patches matched in appearance to the Active 14 mg and 7 mg nicotine patches used in the Nicotine patch intervention. See arms for specific durations.

OTHER

Placebo Pill

Placebo pills matched in appearance to the Active Varenicline pills in the Varenicline intervention. See arms for specific durations. (Active and placebo varenicline pills provided at no cost through an independent research agreement with Pfizer.)

Trial Locations (2)

53233

UW Center for Tobacco Research and Intervention, Milwaukee

53711

UW Center For Tobacco Research and Intervention, Madison

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT03176784 - UW Quitting Using Intensive Treatment Study (QUITS) | Biotech Hunter | Biotech Hunter